Public companies are turning their corporate treasuries into AI pre-IPO vehicles. Genius Group (NYSE American: GNS) became the latest when its board approved a structured allocation strategy targeting eight of the most closely held names in private AI, and it’s doing it under a regulatory constraint most investors haven’t thought through.
According to the company’s May 27 announcement, Genius Group’s board approved a total $100 million allocation it has labeled the “AGI Infinity Portfolio.” Phase One commits $20 million toward pre-IPO fund exposure to SpaceX, OpenAI, Anthropic, Figure AI, Databricks, Anduril, Replit, and Shield AI. The remaining $80 million follows in subsequent phases. The company states it’s partially funding the strategy through what it describes as an existing $1.2 billion at-the-market equity facility, though that figure comes from the company’s own disclosure and hasn’t been independently confirmed.
The real story isn’t the eight names. It’s the regulatory architecture constraining this trade.
Genius Group states the portfolio is structured to remain below 40% of corporate assets, a threshold consistent with the asset test under the Investment Company Act of 1940 that determines whether a public company must register as an investment company. That’s a real constraint. Cross the line and GNS doesn’t just have a treasury strategy, it has a compliance problem with the SEC. The company’s stated awareness of this threshold suggests its legal team has done the work. But no independent analysis confirms the specific compliance framing as of this announcement.
The forward-looking numbers are management projections, not facts. Genius Group is targeting an $800 million treasury and $2 billion in total assets by FY2031, a five-year horizon from a company whose current market profile is small-cap. According to corporate disclosure reviewed by Stock Titan, these targets haven’t been reviewed by external analysts.
Context and precedent
This isn’t the first time a public company has restructured its balance sheet around private AI exposure. The pattern has precedent across the hub’s documented coverage of where AI capital is actually going in 2026 and the mechanics of pre-IPO pricing in frontier lab economics. What’s different here is the actor profile. Genius Group isn’t a hedge fund or a family office, it’s a publicly traded company doing this through an at-market equity facility. That means retail shareholders are, indirectly, buying pre-IPO AI exposure through their GNS position.
What to Watch
What to watch
Three signals matter in the coming months. First: does Genius Group file an amendment or new registration with the SEC confirming the ATM facility and the portfolio structure? That filing would independently verify the $1.2 billion figure and the compliance framing. Second: does the company actually deploy the $20 million Phase One, and to which funds? Named targets (SpaceX, OpenAI, Anthropic) aren’t confirmed investments, they’re stated intentions. Third: watch whether other small-cap and mid-cap public companies adopt similar treasury strategies. One announcement is a data point. Three is a structural shift in how public markets access private AI upside.
TJS synthesis
The Genius Group announcement is less significant as a standalone event than as an early indicator of a pattern. Institutional capital, sovereign wealth funds, top-tier venture, corporate strategics, has dominated the pre-IPO AI market. Now public companies with retail investor bases are engineering their balance sheets to get the same exposure. The Investment Company Act constraint is a real ceiling on how far this can go. Watch whether any of these companies breach that threshold, which would force a registration decision with the SEC, and would make the corporate treasury strategy a compliance story, not just a capital markets story.